Indian markets are likely to kick off August series on a subdued note as the GIFT Nifty is trading lower this morning. Meanwhile, on Wall Street the Dow has snapped a 13-day winning streak after US GDP data came in higher than expectations. Among stocks in focus this morning, Lupin’s US FDA headache eases while BEL reports strong numbers. We’ll also take stock of the Q1 report card of I.T giants. Catch Nandita Khemka in conversation with Madhuchanda Dey, Moneycontrol Pro and Hemen Kapadia, KR Choksey Shares & Securities.
first published: Jul 28, 2023 08:33 am
A collection of the most-viewed Moneycontrol videos.
Sensex, Nifty resume rally after 2-day pause, financials shine bright | Closing Bell
Maran Govindasamy of Unifi Capital on Investment Insights from India’s Consumption Story
Nifty Bulls Likely To Tread With Caution With Eye On Axis Bank Q2 Earnings |Opening Bell Live
Live: Nifty slips below 25,200, LG Electronics shares down after blockbuster debut | Closing Bell
Is it a good time to enter Bajaj Finance post Q3 business update? | Opening Bell
Live: Will Nifty reclaim 22,200 or test 22,000 in expiry week? Vodafone Idea, Canara Bank in focus
Live: Indian market poised to clock new highs in monthly F&O expiry week? RIL, HDFC Bank in focus
Live: Nifty poised to extend record run; Should you buy Grasim after Birla opus launch?| Vi in focus
Live: Nifty braces for another see-saw session; Will banks make a comeback? GPT Healthcare IPO opens
